- Published on
Emergency And Acute Medicine - Ehrlichiosis
Foundational overview
Ehrlichiosis is a tick-transmitted human infection that typically presents as a nonspecific febrile illness. Multiple forms exist, but two predominate in North America. Human monocytic ehrlichiosis was first recognized in 1987 and is transmitted by the lone star tick, Amblyomma americanum, with distribution primarily in the central, southern, and mid-Atlantic United States and expansion into parts of New England. Human granulocytic ehrlichiosis, also known as human granulocytic anaplasmosis, was described in 1994 and is transmitted by Ixodes scapularis, the same vector responsible for Lyme disease. Although all forms are tick borne, they differ in vectors and geographic distribution, with HME and HGE/HGA representing the clinically most relevant pathogens.
Causative organisms and pathogenesis
Ehrlichiosis is caused by obligate intracellular bacteria. Human monocytic ehrlichiosis results from infection with Ehrlichia chaffeensis, whereas human granulocytic ehrlichiosis/anaplasmosis is caused by Anaplasma phagocytophila. Taxonomic classification has evolved with advances in molecular diagnostics. Unlike Rocky Mountain spotted fever, vasculitis is typically absent. A third clinically similar infection caused by Ehrlichia ewingii may occur, also transmitted by the lone star tick. Compared with RMSF, ehrlichiosis more commonly affects adults over 40 years of age.
Clinical manifestations and symptom patterns
The clinical features of HME and HGE/HGA are largely overlapping. Many infected individuals experience asymptomatic seroconversion, and reported cases often represent more severe illness. Coinfection with other tick-borne pathogens from a single bite may complicate the presentation. Approximately one-quarter of pediatric patients develop severe disease.
Historical features
Epidemiologic context is critical. Most cases occur between April and October, with seasonal variability related to climate and geography. Symptoms typically begin 1–2 weeks after a tick bite, with a median onset of 9–10 days. Patients may recall a lone star tick bite more readily than a deer tick bite. Onset is often abrupt and includes fever, chills, headache, myalgias, and malaise. Rash is common in HME but infrequent in HGE/HGA and is often delayed. Severe illness may involve complications such as acute respiratory distress syndrome, renal failure, shock, rhabdomyolysis, gastrointestinal symptoms, central or peripheral nervous system involvement, seizures, or disseminated intravascular coagulation. Immunocompromised patients are at higher risk for severe outcomes.
Physical examination findings
Patients are typically febrile. Rash, when present, may be macular, maculopapular, or petechial and usually involves the trunk while sparing the palms and soles. Lymphadenopathy and hepatosplenomegaly may occur. Neurologic abnormalities can include altered mental status or meningismus, and pulmonary findings such as rales or rhonchi may be evident in patients with respiratory complications. In children, fever, headache, and rash are common, with lymphadenopathy frequently noted.
Essential diagnostic approach
Ehrlichiosis is primarily a clinical diagnosis and should be considered in patients with undifferentiated febrile illness during warm months, particularly with possible tick exposure. The CDC defines the illness as fever accompanied by symptoms such as headache, myalgia, cytopenias, or elevated transaminases, along with confirmatory laboratory evidence.
Laboratory evaluation and interpretation
Common laboratory abnormalities include leukopenia, thrombocytopenia, anemia, and elevated hepatic transaminases, often two to six times normal. Indirect immunofluorescence antibody testing is widely available and highly sensitive when paired acute and convalescent samples are obtained. Peripheral blood smear may reveal morulae, more commonly in HGE/HGA than HME, though sensitivity varies. PCR and culture testing are not routinely available. Lumbar puncture may show lymphocytic pleocytosis and elevated protein. Imaging is guided by complications, including head CT for encephalopathy and chest radiography for respiratory symptoms.
Conditions to distinguish from ehrlichiosis
The differential diagnosis includes other tick-borne illnesses such as Rocky Mountain spotted fever, Lyme disease, and babesiosis, as well as viral syndromes, mononucleosis, thrombotic thrombocytopenic purpura, hematologic malignancies, cholangitis, and pneumonia.
Initial stabilization principles
Standard airway, breathing, and circulation assessment should be performed in all patients.
Emergency department management
Empiric antimicrobial therapy should be initiated promptly when ehrlichiosis is suspected. Doxycycline is the treatment of choice for adults and children, including those under 9 years of age, as short courses have not been shown to cause clinically significant tooth discoloration. Therapy should continue for at least three days after fever resolution, with a minimum total course of seven days; longer treatment is required for severe disease. Rifampin may be used in pregnant patients, those with doxycycline allergy, or mildly affected young children. Coverage for other potential coinfections should be considered.
Medication considerations
Doxycycline is administered at 100 mg IV or orally every 12 hours in adults. Pediatric dosing is weight based, up to adult maximums. Despite typical age-related contraindications, doxycycline remains the drug of choice for severe pediatric disease. Rifampin is an alternative in selected populations. In pregnancy, rifampin is preferred, though doxycycline may be considered in life-threatening illness.
Disposition and follow-up planning
Hospital admission is recommended for patients with severe disease, significant comorbidities, immunosuppression, or inability to tolerate oral therapy. The case fatality rate for HME may reach 3%. Patients with mild illness who appear clinically stable may be discharged with close follow-up, as symptoms usually resolve within one to two weeks, though rare long-term neurologic sequelae have been reported.
Referral considerations
Specialty consultation is indicated for patients with severe or complicated disease.
Key clinical insights and common errors
Ehrlichiosis is a potentially fatal but treatable tick-borne illness that is frequently diagnosed clinically. Failure to consider it in patients with nonspecific febrile illness during tick season is a common error. Early initiation of doxycycline significantly improves outcomes and should not be delayed pending confirmatory testing. Coinfection with other tick-borne pathogens should always be considered, particularly in endemic regions.
Foundational overview
Ehrlichiosis is a tick-transmitted human infection that typically presents as a nonspecific febrile illness. Multiple forms exist, but two predominate in North America. Human monocytic ehrlichiosis was first recognized in 1987 and is transmitted by the lone star tick, Amblyomma americanum, with distribution primarily in the central, southern, and mid-Atlantic United States and expansion into parts of New England. Human granulocytic ehrlichiosis, also known as human granulocytic anaplasmosis, was described in 1994 and is transmitted by Ixodes scapularis, the same vector responsible for Lyme disease. Although all forms are tick borne, they differ in vectors and geographic distribution, with HME and HGE/HGA representing the clinically most relevant pathogens.
Causative organisms and pathogenesis
Ehrlichiosis is caused by obligate intracellular bacteria. Human monocytic ehrlichiosis results from infection with Ehrlichia chaffeensis, whereas human granulocytic ehrlichiosis/anaplasmosis is caused by Anaplasma phagocytophila. Taxonomic classification has evolved with advances in molecular diagnostics. Unlike Rocky Mountain spotted fever, vasculitis is typically absent. A third clinically similar infection caused by Ehrlichia ewingii may occur, also transmitted by the lone star tick. Compared with RMSF, ehrlichiosis more commonly affects adults over 40 years of age.
Clinical manifestations and symptom patterns
The clinical features of HME and HGE/HGA are largely overlapping. Many infected individuals experience asymptomatic seroconversion, and reported cases often represent more severe illness. Coinfection with other tick-borne pathogens from a single bite may complicate the presentation. Approximately one-quarter of pediatric patients develop severe disease.
Historical features
Epidemiologic context is critical. Most cases occur between April and October, with seasonal variability related to climate and geography. Symptoms typically begin 1–2 weeks after a tick bite, with a median onset of 9–10 days. Patients may recall a lone star tick bite more readily than a deer tick bite. Onset is often abrupt and includes fever, chills, headache, myalgias, and malaise. Rash is common in HME but infrequent in HGE/HGA and is often delayed. Severe illness may involve complications such as acute respiratory distress syndrome, renal failure, shock, rhabdomyolysis, gastrointestinal symptoms, central or peripheral nervous system involvement, seizures, or disseminated intravascular coagulation. Immunocompromised patients are at higher risk for severe outcomes.
Physical examination findings
Patients are typically febrile. Rash, when present, may be macular, maculopapular, or petechial and usually involves the trunk while sparing the palms and soles. Lymphadenopathy and hepatosplenomegaly may occur. Neurologic abnormalities can include altered mental status or meningismus, and pulmonary findings such as rales or rhonchi may be evident in patients with respiratory complications. In children, fever, headache, and rash are common, with lymphadenopathy frequently noted.
Essential diagnostic approach
Ehrlichiosis is primarily a clinical diagnosis and should be considered in patients with undifferentiated febrile illness during warm months, particularly with possible tick exposure. The CDC defines the illness as fever accompanied by symptoms such as headache, myalgia, cytopenias, or elevated transaminases, along with confirmatory laboratory evidence.
Laboratory evaluation and interpretation
Common laboratory abnormalities include leukopenia, thrombocytopenia, anemia, and elevated hepatic transaminases, often two to six times normal. Indirect immunofluorescence antibody testing is widely available and highly sensitive when paired acute and convalescent samples are obtained. Peripheral blood smear may reveal morulae, more commonly in HGE/HGA than HME, though sensitivity varies. PCR and culture testing are not routinely available. Lumbar puncture may show lymphocytic pleocytosis and elevated protein. Imaging is guided by complications, including head CT for encephalopathy and chest radiography for respiratory symptoms.
Conditions to distinguish from ehrlichiosis
The differential diagnosis includes other tick-borne illnesses such as Rocky Mountain spotted fever, Lyme disease, and babesiosis, as well as viral syndromes, mononucleosis, thrombotic thrombocytopenic purpura, hematologic malignancies, cholangitis, and pneumonia.
Initial stabilization principles
Standard airway, breathing, and circulation assessment should be performed in all patients.
Emergency department management
Empiric antimicrobial therapy should be initiated promptly when ehrlichiosis is suspected. Doxycycline is the treatment of choice for adults and children, including those under 9 years of age, as short courses have not been shown to cause clinically significant tooth discoloration. Therapy should continue for at least three days after fever resolution, with a minimum total course of seven days; longer treatment is required for severe disease. Rifampin may be used in pregnant patients, those with doxycycline allergy, or mildly affected young children. Coverage for other potential coinfections should be considered.
Medication considerations
Doxycycline is administered at 100 mg IV or orally every 12 hours in adults. Pediatric dosing is weight based, up to adult maximums. Despite typical age-related contraindications, doxycycline remains the drug of choice for severe pediatric disease. Rifampin is an alternative in selected populations. In pregnancy, rifampin is preferred, though doxycycline may be considered in life-threatening illness.
Disposition and follow-up planning
Hospital admission is recommended for patients with severe disease, significant comorbidities, immunosuppression, or inability to tolerate oral therapy. The case fatality rate for HME may reach 3%. Patients with mild illness who appear clinically stable may be discharged with close follow-up, as symptoms usually resolve within one to two weeks, though rare long-term neurologic sequelae have been reported.
Referral considerations
Specialty consultation is indicated for patients with severe or complicated disease.
Key clinical insights and common errors
Ehrlichiosis is a potentially fatal but treatable tick-borne illness that is frequently diagnosed clinically. Failure to consider it in patients with nonspecific febrile illness during tick season is a common error. Early initiation of doxycycline significantly improves outcomes and should not be delayed pending confirmatory testing. Coinfection with other tick-borne pathogens should always be considered, particularly in endemic regions.
0 Comments
